Logo image of AQST

AQUESTIVE THERAPEUTICS INC (AQST) Stock Earnings Estimates

USA - Nasdaq - NASDAQ:AQST - US03843E1047 - Common Stock

3.24 USD
-0.23 (-6.63%)
Last: 1/28/2026, 8:00:01 PM
3.2584 USD
+0.02 (+0.57%)
After Hours: 1/28/2026, 8:00:01 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
AQST revenue by date.AQST revenue by date.
47.68M
-6.20%
50.583M
6.09%
57.561M
13.80%
45.705M
-20.60%
65.369M
43.02%
96.922M
48.27%
175.66M
81.24%
233.35M
32.84%
389.19M
66.78%
438.91M
12.78%
584.36M
33.14%
712.57M
21.94%
EBITDA
YoY % growth
AQST ebitda by date.AQST ebitda by date.
-39.68M
-25.09%
-13.757M
65.33%
-30.053M
-118.46%
-48.417M
-61.11%
-57.815M
-19.41%
-16.218M
71.95%
40.086M
347.17%
46.716M
16.54%
173.2M
270.75%
217.16M
25.38%
N/AN/A
EBIT
YoY % growth
AQST ebit by date.AQST ebit by date.
-42.07M
-21.31%
-15.102M
64.10%
-30.771M
-103.75%
-54.989M
-78.70%
-61.079M
-11.08%
-40.058M
34.42%
32.692M
181.61%
79.812M
144.13%
170.87M
114.09%
143.21M
-16.19%
253.88M
77.28%
355.88M
40.18%
Operating Margin
AQST operating margin by date.AQST operating margin by date.
-88.23%-29.86%-53.46%-120.31%-93.44%-41.33%18.61%34.20%43.90%32.63%43.45%49.94%
EPS
YoY % growth
AQST eps by date.AQST eps by date.
-1.14
23.49%
-0.36
68.42%
-0.52
-44.44%
-0.66
-26.27%
-0.60
9.02%
-0.39
35.12%
-0.02
94.74%
0.21
1,150.00%
N/AN/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.14
28.87%
-0.17
28.60%
-0.18
-26.77%
-0.16
-16.57%
-0.14
-3.77%
Revenue
Q2Q % growth
13.55M
25.91%
11.694M
34.11%
13.81M
38.06%
17.603M
37.45%
22.501M
66.06%
EBITDA
Q2Q % growth
-12.814M
3.51%
-23.185M
-20.59%
-21.615M
-94.92%
-19.259M
-74.11%
-17.688M
-38.04%
EBIT
Q2Q % growth
-12.909M
7.79%
-19.084M
1.45%
-20.431M
-79.72%
-19.646M
-71.14%
-17.463M
-35.28%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.14
-7.69%
-0.140.00-3.59%
Q2 2025
Q2Q % growth
-0.14
-366.67%
-0.170.0318.46%
Q1 2025
Q2Q % growth
-0.24
-41.18%
-0.17-0.07-38.41%
Q4 2024
Q2Q % growth
-0.19
-72.73%
-0.14-0.05-37.26%
Q3 2024
Q2Q % growth
-0.13
-333.33%
-0.130.00-0.62%
Q2 2024
Q2Q % growth
-0.03
70.00%
-0.130.1076.28%
Q1 2024
Q2Q % growth
-0.17
-41.67%
-0.08-0.09-102.44%
Q4 2023
Q2Q % growth
-0.11
52.17%
-0.08-0.03-34.80%
Q3 2023
Q2Q % growth
-0.03
86.96%
-0.120.0974.02%
Q2 2023
Q2Q % growth
-0.10
72.22%
-0.120.0216.92%
Q1 2023
Q2Q % growth
-0.12
62.50%
-0.190.0737.75%
Q4 2022
Q2Q % growth
-0.23
39.47%
-0.240.012.30%
Q3 2022
Q2Q % growth
-0.23
37.84%
-0.320.0927.73%
Q2 2022
Q2Q % growth
-0.36
-9.09%
-0.370.011.96%
Q1 2022
Q2Q % growth
-0.32
21.95%
-0.420.1023.11%
Q4 2021
Q2Q % growth
-0.38
36.67%
-0.480.1020.31%
Q3 2021
Q2Q % growth
-0.37
24.49%
-0.460.0919.39%
Q2 2021
Q2Q % growth
-0.33
-371.43%
-0.450.1226.13%
Q1 2021
Q2Q % growth
-0.41
16.33%
-0.430.025.64%
Q4 2020
Q2Q % growth
-0.60 -0.27-0.33-126.24%
Q3 2020
Q2Q % growth
-0.49 -0.47-0.02-5.35%
Q2 2020
Q2Q % growth
-0.07 -0.440.3784.11%
Q1 2020
Q2Q % growth
-0.49 -0.48-0.01-3.09%
AQST Yearly EPS VS EstimatesAQST Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 -0.5 -1 -1.5 -2 -2.5
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
12.807M
-5.43%
13.202M-395K-2.99%
Q2 2025
Q2Q % growth
10.003M
-50.23%
11.546M-1.543M-13.36%
Q1 2025
Q2Q % growth
8.72M
-27.65%
12.475M-3.755M-30.10%
Q4 2024
Q2Q % growth
10.762M
-2.15%
13.345M-2.583M-19.36%
Q3 2024
Q2Q % growth
13.542M
18.70%
12.937M605K4.68%
Q2 2024
Q2Q % growth
20.099M
51.79%
12.628M7.471M59.16%
Q1 2024
Q2Q % growth
12.053M
8.25%
12.508M-455K-3.64%
Q4 2023
Q2Q % growth
10.998M
2.98%
11.864M-866K-7.30%
Q3 2023
Q2Q % growth
11.409M
-0.45%
11.744M-335K-2.85%
Q2 2023
Q2Q % growth
13.241M
-0.22%
11.232M2.009M17.89%
Q1 2023
Q2Q % growth
11.134M
-9.26%
10.136M998K9.85%
Q4 2022
Q2Q % growth
10.68M
-3.61%
10.625M55K0.52%
Q3 2022
Q2Q % growth
11.46M
-13.77%
11.258M202K1.79%
Q2 2022
Q2Q % growth
13.27M
-13.55%
10.784M2.486M23.05%
Q1 2022
Q2Q % growth
12.27M
10.34%
10.313M1.957M18.98%
Q4 2021
Q2Q % growth
11.08M
54.97%
9.549M1.531M16.03%
Q3 2021
Q2Q % growth
13.29M
60.90%
11.234M2.056M18.30%
Q2 2021
Q2Q % growth
15.35M
-29.20%
9.665M5.685M58.82%
Q1 2021
Q2Q % growth
11.12M
26.80%
9.147M1.973M21.57%
Q4 2020
Q2Q % growth
7.15M 6.377M773K12.12%
Q3 2020
Q2Q % growth
8.26M 8.897M-637K-7.16%
Q2 2020
Q2Q % growth
21.68M 8.941M12.739M142.48%
Q1 2020
Q2Q % growth
8.77M 10.274M-1.504M-14.64%
AQST Yearly Revenue VS EstimatesAQST Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS4.5% 8.62% 0.39% 0.28%
Revenue-0.43% -0.4% -0.12% -0.38%